A paroxizmális pitvarfibrilláció kezelésének új módszere: Cryoballonos pulmonalis véna cirkumferenciális ablatiója

Translated title of the contribution: New therapy for atrial fibrillation: Pulmonary vein isolation by cryoballoon ablation

Csaba László Fóldesi, A. Kardos, Attila Mihálcz, Zoltán Som, Gabriella Hódi, P. Andréka, Tamás Szili-Török

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Atrial fibrillation is the most frequent arrhythmia with increasing prevalence. Given a limited success rate of drug therapy for atrial fibrillation, interventional treatment options have been developed during the last years. Catheter ablation of atrial fibrillation (until recently the mostly used energy source was radiofrequency energy) has been established as an important therapeutic alternative. Depending on interpersonal (both on patient and operator side) and technical variabilities using radiofrequency energy potentially life-threatening complications such as pulmonary vein stenosis or atrio-esophageal fistulas may occur. Cryoenergy is a novel energy source for transcatheter ablation eliminating the arrhythmia substrate by freezing. The cornerstone of catheter ablation for atrial fibrillation is electrical isolation of the pulmonary veins. During cryoballoon ablation the targeted pulmonary vein transiently occluded by the inflated balloon catheter and using this method a circumferential lesion is created. The success rate of cryoballoon ablation is comparable with the radiofrequency ablation with increased safety. We performed the first cryoballoon ablations for patients with paroxysmal atrial fibrillation in Hungary. On this occasion we review the potential advantages of this technique which may serve as basis for its widespread use in the future.

Original languageHungarian
Pages (from-to)1779-1784
Number of pages6
JournalOrvosi Hetilap
Volume149
Issue number38
DOIs
Publication statusPublished - Sep 21 2008

Fingerprint

Pulmonary Veins
Atrial Fibrillation
Catheter Ablation
Cardiac Arrhythmias
Esophageal Fistula
Therapeutics
Hungary
Freezing
Catheters
Safety
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A paroxizmális pitvarfibrilláció kezelésének új módszere : Cryoballonos pulmonalis véna cirkumferenciális ablatiója. / Fóldesi, Csaba László; Kardos, A.; Mihálcz, Attila; Som, Zoltán; Hódi, Gabriella; Andréka, P.; Szili-Török, Tamás.

In: Orvosi Hetilap, Vol. 149, No. 38, 21.09.2008, p. 1779-1784.

Research output: Contribution to journalArticle

Fóldesi, Csaba László ; Kardos, A. ; Mihálcz, Attila ; Som, Zoltán ; Hódi, Gabriella ; Andréka, P. ; Szili-Török, Tamás. / A paroxizmális pitvarfibrilláció kezelésének új módszere : Cryoballonos pulmonalis véna cirkumferenciális ablatiója. In: Orvosi Hetilap. 2008 ; Vol. 149, No. 38. pp. 1779-1784.
@article{700eac0d5c5f4c99b2db48f3cbd83261,
title = "A paroxizm{\'a}lis pitvarfibrill{\'a}ci{\'o} kezel{\'e}s{\'e}nek {\'u}j m{\'o}dszere: Cryoballonos pulmonalis v{\'e}na cirkumferenci{\'a}lis ablati{\'o}ja",
abstract = "Atrial fibrillation is the most frequent arrhythmia with increasing prevalence. Given a limited success rate of drug therapy for atrial fibrillation, interventional treatment options have been developed during the last years. Catheter ablation of atrial fibrillation (until recently the mostly used energy source was radiofrequency energy) has been established as an important therapeutic alternative. Depending on interpersonal (both on patient and operator side) and technical variabilities using radiofrequency energy potentially life-threatening complications such as pulmonary vein stenosis or atrio-esophageal fistulas may occur. Cryoenergy is a novel energy source for transcatheter ablation eliminating the arrhythmia substrate by freezing. The cornerstone of catheter ablation for atrial fibrillation is electrical isolation of the pulmonary veins. During cryoballoon ablation the targeted pulmonary vein transiently occluded by the inflated balloon catheter and using this method a circumferential lesion is created. The success rate of cryoballoon ablation is comparable with the radiofrequency ablation with increased safety. We performed the first cryoballoon ablations for patients with paroxysmal atrial fibrillation in Hungary. On this occasion we review the potential advantages of this technique which may serve as basis for its widespread use in the future.",
keywords = "Arrhytmia, Atrial fibrillation, Catheter ablation, Cryoballoon, Pulmonary veins",
author = "F{\'o}ldesi, {Csaba L{\'a}szl{\'o}} and A. Kardos and Attila Mih{\'a}lcz and Zolt{\'a}n Som and Gabriella H{\'o}di and P. Andr{\'e}ka and Tam{\'a}s Szili-T{\"o}r{\"o}k",
year = "2008",
month = "9",
day = "21",
doi = "10.1556/OH.2008.28454",
language = "Hungarian",
volume = "149",
pages = "1779--1784",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "38",

}

TY - JOUR

T1 - A paroxizmális pitvarfibrilláció kezelésének új módszere

T2 - Cryoballonos pulmonalis véna cirkumferenciális ablatiója

AU - Fóldesi, Csaba László

AU - Kardos, A.

AU - Mihálcz, Attila

AU - Som, Zoltán

AU - Hódi, Gabriella

AU - Andréka, P.

AU - Szili-Török, Tamás

PY - 2008/9/21

Y1 - 2008/9/21

N2 - Atrial fibrillation is the most frequent arrhythmia with increasing prevalence. Given a limited success rate of drug therapy for atrial fibrillation, interventional treatment options have been developed during the last years. Catheter ablation of atrial fibrillation (until recently the mostly used energy source was radiofrequency energy) has been established as an important therapeutic alternative. Depending on interpersonal (both on patient and operator side) and technical variabilities using radiofrequency energy potentially life-threatening complications such as pulmonary vein stenosis or atrio-esophageal fistulas may occur. Cryoenergy is a novel energy source for transcatheter ablation eliminating the arrhythmia substrate by freezing. The cornerstone of catheter ablation for atrial fibrillation is electrical isolation of the pulmonary veins. During cryoballoon ablation the targeted pulmonary vein transiently occluded by the inflated balloon catheter and using this method a circumferential lesion is created. The success rate of cryoballoon ablation is comparable with the radiofrequency ablation with increased safety. We performed the first cryoballoon ablations for patients with paroxysmal atrial fibrillation in Hungary. On this occasion we review the potential advantages of this technique which may serve as basis for its widespread use in the future.

AB - Atrial fibrillation is the most frequent arrhythmia with increasing prevalence. Given a limited success rate of drug therapy for atrial fibrillation, interventional treatment options have been developed during the last years. Catheter ablation of atrial fibrillation (until recently the mostly used energy source was radiofrequency energy) has been established as an important therapeutic alternative. Depending on interpersonal (both on patient and operator side) and technical variabilities using radiofrequency energy potentially life-threatening complications such as pulmonary vein stenosis or atrio-esophageal fistulas may occur. Cryoenergy is a novel energy source for transcatheter ablation eliminating the arrhythmia substrate by freezing. The cornerstone of catheter ablation for atrial fibrillation is electrical isolation of the pulmonary veins. During cryoballoon ablation the targeted pulmonary vein transiently occluded by the inflated balloon catheter and using this method a circumferential lesion is created. The success rate of cryoballoon ablation is comparable with the radiofrequency ablation with increased safety. We performed the first cryoballoon ablations for patients with paroxysmal atrial fibrillation in Hungary. On this occasion we review the potential advantages of this technique which may serve as basis for its widespread use in the future.

KW - Arrhytmia

KW - Atrial fibrillation

KW - Catheter ablation

KW - Cryoballoon

KW - Pulmonary veins

UR - http://www.scopus.com/inward/record.url?scp=53849141225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849141225&partnerID=8YFLogxK

U2 - 10.1556/OH.2008.28454

DO - 10.1556/OH.2008.28454

M3 - Article

C2 - 18805763

AN - SCOPUS:53849141225

VL - 149

SP - 1779

EP - 1784

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 38

ER -